NDI-219216

· Nimbus Wadjet, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDI-219216, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]

See pricing